Long QT Syndrome Diagnosis & Treatments – Addressing the Gaps
Long QT Syndrome Diagnosis & Treatments – Addressing the Gaps
Thursday, October 23, 2025 at 11:00 am PT | 2:00 pm ET
This webinar on Long QT Syndrome (LQTS) will review current best practices in diagnosis, risk stratification, and management—including pharmacologic, device-based, and lifestyle interventions—while highlighting ongoing challenges and treatment gaps. Designed for cardiologists, electrophysiologists, and allied professionals, this one-hour panel discussion will provide evidence-based insights to support improved patient care and identify areas where further advances are needed.
The webinar includes a panel discussion of LQTS – diagnosis, genetic testing, current therapies along with unmet needs & expectations for new treatments. Panelists include Dr. Peter Aziz of Cleveland Clinic, Dr. Adam Helms of University of Michigan and Dr. Wojciech Zareba of University of Rochester with the discussion moderated by Dr. Barbara Troupin.
Learning Objectives
Recognize the clinical features and genetic basis of Long QT Syndrome (LQTS) that inform timely diagnosis.
Apply current evidence-based approaches to risk stratification and treatment, including pharmacologic therapies, implantable devices, and lifestyle modifications.
Evaluate emerging strategies and research directions aimed at improving outcomes for patients with LQTS.
Identify challenges in diagnosis and management, including overlapping presentations and gaps in current guidelines.
Thryv Therapeutics is supporting this webinar with a grant to the SADS Foundation.
